These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 3492554)

  • 1. Carrier-specific suppression of antibody responses by antigen-specific glycosylation-inhibiting factors.
    Jardieu P; Akasaki M; Ishizaka K
    J Immunol; 1987 Mar; 138(5):1494-501. PubMed ID: 3492554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive effects of glycosylation inhibiting factor on the IgE and IgG antibody response.
    Akasaki M; Jardieu P; Ishizaka K
    J Immunol; 1986 May; 136(9):3172-9. PubMed ID: 2937840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of antigen-specific suppressor T cell hybridomas from spleen cells of mice primed for the persistent IgE antibody formation.
    Iwata M; Ishizaka K
    J Immunol; 1988 Nov; 141(10):3270-7. PubMed ID: 2460527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of an antigen-specific T cell subset that forms IgE-suppressive factor and IgG-suppressive factor on antigenic stimulation.
    Jardieu P; Uede T; Ishizaka K
    J Immunol; 1985 Aug; 135(2):922-9. PubMed ID: 2409160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgE-binding factors from mouse T lymphocytes. III. Role of antigen-specific suppressor T cells in the formation of IgE-suppressive factor.
    Jardieu P; Uede T; Ishizaka K
    J Immunol; 1984 Dec; 133(6):3266-73. PubMed ID: 6208275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-specific T cells that form IgE-potentiating factor, IgG-potentiating factor, and antigen-specific glycosylation-enhancing factor on antigenic stimulation.
    Iwata M; Adachi M; Ishizaka K
    J Immunol; 1988 Apr; 140(8):2534-42. PubMed ID: 3258613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of glycosylation-inhibiting factor with plasma membranes of T suppressor cell hybridomas.
    Iwata M; Katamura K; Mori A; Yamagushi K; Grey H; Ishizaka K
    J Immunol; 1990 Dec; 145(11):3578-88. PubMed ID: 2147196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reaginic antibody formation in the mouse. VII. Induction of suppressor T cells for IgE and IgG antibody responses.
    Takatsu K; Ishizaka K
    J Immunol; 1976 May; 116(5):1257-64. PubMed ID: 1083868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical characterization of antigen-specific glycosylation-inhibiting factor from antigen-specific suppressor T cells. I. Identification of a 55-kilodalton glycosylation-inhibiting factor peptide with TCR alpha-chain determinant.
    Nakano T; Ishii Y; Ishizaka K
    J Immunol; 1996 Mar; 156(5):1728-34. PubMed ID: 8596020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of specific helper cells and suppressor cells in vitro for the IgE and IgG antibody responses.
    Ishizaka K; Adachi T
    J Immunol; 1976 Jul; 117(1):40-7. PubMed ID: 1084370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirement of certain epitope specificities of glycosylation inhibiting factor for the suppression of in vivo IgE and IgG antibody responses.
    Yamaguchi K; Mori A; Ohno H; Tagaya Y; Ishizaka K
    Int Immunol; 1992 Mar; 4(3):337-46. PubMed ID: 1373642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between T cell receptors and antigen-binding factors. I. Specificity of functional T cell receptors on mouse T cell hybridomas that produce antigen-binding T cell factors.
    Iwata M; Katamura K; Kubo RT; Ishizaka K
    J Immunol; 1989 Dec; 143(12):3909-16. PubMed ID: 2480378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgE-binding factors and regulation of the IgE antibody response.
    Ishizaka K
    Annu Rev Immunol; 1988; 6():513-34. PubMed ID: 3289576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosylation-inhibiting factor from human T cell hybridomas constructed from peripheral blood lymphocytes of a bee venom-sensitive allergic patient.
    Thomas P; Gomi H; Takeuchi T; Carini C; Tagaya Y; Ishizaka K
    J Immunol; 1992 Feb; 148(3):729-37. PubMed ID: 1730869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttranslational modification of the glycosylation inhibiting factor (GIF) gene product generates bioactive GIF.
    Watarai H; Nozawa R; Tokunaga A; Yuyama N; Tomas M; Hinohara A; Ishizaka K; Ishii Y
    Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13251-6. PubMed ID: 11069294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reaginic antibody formation in the mouse. V. Adoptive antihapten IgE antibody response of dinitrophenyl-keyhole limpet hemocyanin-primed spleen cells cultured with dinitrophenyl heterologous carrier conjugates.
    Okudaira H; Ishizaka K
    J Immunol; 1975 Feb; 114(2 Pt 1):615-20. PubMed ID: 47357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgE-binding factors from mouse T lymphocytes. II. Strain differences in the nature of IgE-binding factor.
    Uede T; Ishizaka K
    J Immunol; 1984 Jul; 133(1):359-67. PubMed ID: 6609987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A monoclonal antibody raised to lipomodulin recognizes T suppressor factors in two independent hapten-specific suppressor networks.
    Steele JK; Kuchroo VK; Kawasaki H; Jayaraman S; Iwata M; Ishizaka K; Dorf ME
    J Immunol; 1989 Apr; 142(7):2213-20. PubMed ID: 2466892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic and physicochemical properties of enhancing soluble factors for IgG and IgE antibody responses.
    Kishmoto T; Ishizaka K
    J Immunol; 1975 Apr; 114(4):1177-84. PubMed ID: 1167880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of the antibody response by antigen-specific glycosylation-enhancing factor.
    Iwata M; Fukutomi Y; Hashimoto T; Sato Y; Sato H; Ishizaka K
    J Immunol; 1987 Apr; 138(8):2561-7. PubMed ID: 3494077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.